Novavax (NVAX) Inventory Average (2022 - 2026)
Novavax (NVAX) posted quarterly Inventory Average of $11.5 million for Q1 2026, up 20.99% year-over-year from $9.5 million in Q1 2025, and down 8.19% quarter-over-quarter from $12.5 million in Q4 2025.
Novavax (NVAX) Inventory Average (2022 - 2026) Analysis & Trends
Novavax's Inventory Average history runs 5 years deep, the most recent figure standing at $11.5 million for Q1 2026.
- In Q1 2026, Inventory Average rose 20.99% year-over-year to $11.5 million; the TTM figure through Mar 2026 stood at $11.5 million (up 20.99% YoY), while the FY2025 annual figure was $10.1 million, down 59.77% from the prior year.
- Inventory Average for Q1 2026 stood at $11.5 million, down from $12.5 million in the prior quarter.
- The five-year high for Inventory Average was $181.5 million in Q2 2022, with the low at $8.7 million in Q4 2024.
- The 5-year median for Inventory Average is $28.7 million (2024), against an average of $44.1 million.
- The sharpest annual moves came in 2024 and 2025: Inventory Average plunged 84.38% in 2024, then surged 44.11% in 2025.
- Novavax's Inventory Average stood at $59.6 million in 2022, then dropped by 6.57% to $55.6 million in 2023, then slumped by 84.38% to $8.7 million in 2024, then soared by 44.11% to $12.5 million in 2025, then declined by 8.19% to $11.5 million in 2026.
- Business Quant data shows NVAX's Inventory Average at $11.5 million in Q1 2026, $12.5 million in Q4 2025, and $11.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 1.77 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 3.09 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 707.10 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 355,998.06 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 90.57 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 137.65 Mn |
| 10 | Novavax | 1.33 Bn | 607.37 Mn | 42.45 Mn | 10.73 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 10.73 Mn |
| Mar 31, 2026 | 11.50 Mn |
| Dec 31, 2025 | 12.53 Mn |
| Sep 30, 2025 | 11.88 Mn |
| Jun 30, 2025 | 10.25 Mn |
| Mar 31, 2025 | 9.51 Mn |
| Dec 31, 2024 | 8.69 Mn |
| Sep 30, 2024 | 8.91 Mn |
| Jun 30, 2024 | 12.48 Mn |
| Mar 31, 2024 | 28.74 Mn |
| Dec 31, 2023 | 55.64 Mn |
| Sep 30, 2023 | 46.54 Mn |
| Jun 30, 2023 | 28.84 Mn |
| Mar 31, 2023 | 35.43 Mn |
| Dec 31, 2022 | 59.56 Mn |
| Sep 30, 2022 | 169.37 Mn |
| Jun 30, 2022 | 181.47 Mn |
| Mar 31, 2022 | 57.76 Mn |